Maryland State Retirement & Pension System Has $3 Million Stock Holdings in Axon Enterprise, Inc $AXON

Maryland State Retirement & Pension System increased its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 8.0% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 3,626 shares of the biotechnology company’s stock after purchasing an additional 270 shares during the period. Maryland State Retirement & Pension System’s holdings in Axon Enterprise were worth $3,002,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in the business. Vanguard Group Inc. lifted its position in shares of Axon Enterprise by 2.2% during the 1st quarter. Vanguard Group Inc. now owns 8,632,008 shares of the biotechnology company’s stock worth $4,540,005,000 after purchasing an additional 185,571 shares during the last quarter. Alliancebernstein L.P. raised its holdings in Axon Enterprise by 15.9% in the 1st quarter. Alliancebernstein L.P. now owns 1,284,935 shares of the biotechnology company’s stock valued at $675,812,000 after acquiring an additional 175,890 shares in the last quarter. Westfield Capital Management Co. LP raised its holdings in Axon Enterprise by 29.8% in the 1st quarter. Westfield Capital Management Co. LP now owns 927,801 shares of the biotechnology company’s stock valued at $487,977,000 after acquiring an additional 212,931 shares in the last quarter. Northern Trust Corp raised its holdings in Axon Enterprise by 1.2% in the 1st quarter. Northern Trust Corp now owns 725,720 shares of the biotechnology company’s stock valued at $381,692,000 after acquiring an additional 8,794 shares in the last quarter. Finally, Jennison Associates LLC raised its holdings in Axon Enterprise by 23,203.7% in the 1st quarter. Jennison Associates LLC now owns 614,053 shares of the biotechnology company’s stock valued at $322,961,000 after acquiring an additional 611,418 shares in the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

Insider Activity

In related news, CAO Jennifer H. Mak sold 77 shares of the firm’s stock in a transaction on Monday, September 15th. The stock was sold at an average price of $760.00, for a total transaction of $58,520.00. Following the completion of the sale, the chief accounting officer directly owned 15,003 shares of the company’s stock, valued at $11,402,280. This trade represents a 0.51% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Patrick W. Smith sold 10,000 shares of the firm’s stock in a transaction on Tuesday, October 7th. The shares were sold at an average price of $713.74, for a total value of $7,137,400.00. Following the sale, the chief executive officer directly owned 3,033,982 shares of the company’s stock, valued at $2,165,474,312.68. This represents a 0.33% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 59,932 shares of company stock worth $45,115,616. 4.40% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

Several equities analysts have commented on AXON shares. JMP Securities reaffirmed a “market outperform” rating and issued a $825.00 price target on shares of Axon Enterprise in a report on Monday, September 29th. Morgan Stanley set a $885.00 price target on Axon Enterprise and gave the company an “overweight” rating in a report on Friday, July 11th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Axon Enterprise in a report on Wednesday. JPMorgan Chase & Co. upped their price target on Axon Enterprise from $730.00 to $850.00 and gave the company an “overweight” rating in a report on Thursday, July 17th. Finally, Raymond James Financial reaffirmed an “outperform” rating and issued a $855.00 price target (up previously from $645.00) on shares of Axon Enterprise in a report on Tuesday, August 5th. Fourteen research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $841.64.

Axon Enterprise Trading Down 4.2%

Shares of AXON opened at $703.03 on Friday. The stock has a 50 day simple moving average of $755.57 and a 200-day simple moving average of $712.63. Axon Enterprise, Inc has a 1 year low of $422.38 and a 1 year high of $885.91. The stock has a market cap of $55.19 billion, a PE ratio of 173.59, a PEG ratio of 28.50 and a beta of 1.41. The company has a current ratio of 2.95, a quick ratio of 2.71 and a debt-to-equity ratio of 0.63.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings results on Monday, August 4th. The biotechnology company reported $2.12 earnings per share for the quarter, beating analysts’ consensus estimates of $1.54 by $0.58. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The firm had revenue of $668.54 million during the quarter, compared to analysts’ expectations of $641.77 million. During the same period last year, the firm posted $1.20 EPS. The business’s revenue was up 32.6% on a year-over-year basis. Axon Enterprise has set its FY 2025 guidance at EPS. On average, sell-side analysts predict that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.